… -based anticancer therapies, including therapeutic applications of miRNAs, challenges of …
the delivery obstacles, and the development of miRNA delivery systems for cancer therapy. …

… The strategies employed in in vivo miRNA delivery for cancer therapy are … miRNA delivery
and enhance the efficacy of cancer therapy. The first strategy developed for systemic delivery …

… of therapeutic miRNA delivery systems that includes virus-based delivery, non-viral delivery
(… expression versatility emphasizes their utility in cancer therapeutic strategies. Therefore, …

… is faced with several challenges including lack of tissue specificity, lack of optimal delivery
… miRNA delivery system to address some of these challenges. Among many lung cancer …

… is an urgent need for efficient methods to deliver miRNAs. These can be divided into three
… considerations for miRNA delivery for cancer therapy, focusing on nonviral delivery systems…

… therapeutic microRNA delivery strategies and also briefly discuss the different miRNA delivery
… based (LNA-based) compounds delivery without any delivery-mediated agent. Finally, we …

… pHLIP opens the door to the cell: An improved cytosolic transfer of anti-microRNAs (anti-miRs)
against onco-miRs paves the way for future cancer therapies. The employed anti-miR–…

… on the delivery of therapeutic miRNAs into cancerous cells and … evidence addressing
miRNA-based therapeutic approaches … delivery approach to offer effective miRNA cancer therapy. …

… developed for TAM-targeted miR delivery and anti-cancer therapy. The core of nanovectors
… -targeted miR delivery. The results showed that sPEG/GLC successfully delivered miR155 …

… systemic delivery of a synthetic tumor suppressor mimic, obviating obstacles associated
with viral-based miRNA delivery and facilitating a rapid route for miRNA replacement therapy …